Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PPARA | Q07869 | 14/20 | 0.60 |
| ▸ | PPARG | P37231 | 11/20 | 0.60 |
| ▸ | PPARD | Q03181 | 6/20 | 0.49 |
| ▸ | CYP4F2 | P78329 | 2/20 | 0.40 |
| ▸ | CYP4A11 | Q02928 | 2/20 | 0.40 |
| ▸ | ADORA3 | P0DMS8 | 2/20 | 0.38 |
| ▸ | MTNR1A | P48039 | 1/20 | 0.38 |
| ▸ | MTNR1B | P49286 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3844032 | 0.96 | PPARA (0.58) | PPARAPPARGPPARDCYP4F2CYP4A11 | |
| SCHEMBL3841451 | 0.93 | PPARA (0.58) | PPARAPPARGPPARDCYP4F2CYP4A11 | |
| SCHEMBL3839990 | 0.91 | PPARA (0.61) | PPARAPPARGPPARDADORA3 | |
| SCHEMBL3843334 | 0.91 | PPARA (0.60) | PPARAPPARGPPARDCYP4F2CYP4A11 | |
| SCHEMBL3286635 | 0.91 | PPARA (0.62) | PPARAPPARGPPARD | |
| SCHEMBL3844487 | 0.91 | PPARA (0.48) | PPARAPPARGPPARDADORA3MTNR1A | |
| SCHEMBL3844300 | 0.89 | PPARA (0.47) | PPARAPPARGPPARDCYP4F2CYP4A11 | |
| SCHEMBL3840831 | 0.89 | PPARA (0.61) | PPARAPPARGPPARDADORA3 | |
| SCHEMBL3842876 | 0.89 | PPARA (0.56) | PPARAPPARGPPARDADORA3 | |
| SCHEMBL3842820 | 0.88 | PPARA (0.53) | PPARAPPARGPPARDCYP4F2CYP4A11 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1856065-B1 | 1,2,4-TRIAZINE DERIVATIVES, PREPARATION AND USE THEREOF IN HUMAN THERAPY | PF MEDICAMENT (FR) | 2009-11-11 | — | — | EP | claimed |
| EP-1856065-A1 | 1,2,4-TRIAZINE DERIVATIVES, PREPARATION AND USE THEREOF IN HUMAN THERAPY | PIERRE FABRE MEDICAMENT (FR) | 2007-11-21 | — | — | EP | claimed |
| WO-2006092507-A1 | 1,2,4-TRIAZINE DERIVATIVES, PREPARATION AND USE THEREOF IN HUMAN THERAPY | PIERRE FABRE MEDICAMENT (FR) | 2006-09-08 | — | — | WO | claimed |
| EP-1856065-B1 | 1,2,4-TRIAZINE DERIVATIVES, PREPARATION AND USE THEREOF IN HUMAN THERAPY | PF MEDICAMENT (FR) | 2009-11-11 | — | — | EP | disclosed |
| EP-1856065-A1 | 1,2,4-TRIAZINE DERIVATIVES, PREPARATION AND USE THEREOF IN HUMAN THERAPY | PIERRE FABRE MEDICAMENT (FR) | 2007-11-21 | — | — | EP | disclosed |
| WO-2006092507-A1 | 1,2,4-TRIAZINE DERIVATIVES, PREPARATION AND USE THEREOF IN HUMAN THERAPY | PIERRE FABRE MEDICAMENT (FR) | 2006-09-08 | — | — | WO | disclosed |